63984-03-2 Usage
Description
Tert-butyl 5-aminopentanoate is a chemical compound that features a 5-aminopentanoate group attached to a tert-butyl group. It is widely recognized for its role in organic synthesis and its potential applications in the development of pharmaceuticals and biologically active compounds. Its antimicrobial and antifungal properties have garnered interest for its use in creating new drugs and treatments. Furthermore, its low toxicity and stable nature contribute to its reputation as a safe and versatile chemical for research and industrial applications.
Uses
Used in Pharmaceutical Industry:
Tert-butyl 5-aminopentanoate is utilized as a reagent for the synthesis of various pharmaceuticals due to its ability to facilitate the creation of biologically active compounds.
Used in Antimicrobial and Antifungal Applications:
In the field of microbiology, tert-butyl 5-aminopentanoate is employed as an antimicrobial and antifungal agent, leveraging its natural properties to combat infections and develop new treatments.
Used in Research and Development:
Tert-butyl 5-aminopentanoate is used as a key component in research and development for its low toxicity and stable nature, making it an ideal candidate for exploring new chemical reactions and applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 63984-03-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,9,8 and 4 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 63984-03:
(7*6)+(6*3)+(5*9)+(4*8)+(3*4)+(2*0)+(1*3)=152
152 % 10 = 2
So 63984-03-2 is a valid CAS Registry Number.
63984-03-2Relevant articles and documents
SUBSTITUTED 2,3-BENZODIAZEPINES DERIVATIVES
-
Page/Page column 53, (2021/08/06)
Derivatives of 2,3- benzodiazepines as inhibitors of Bromodomain and extra C-terminal domain (BET) proteins, in particular the BRD4 family member, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceuti
Heterovalent inhibitors targeting N-end Rule Pathway and its use
-
, (2016/10/10)
An alkali-soluble polymer resin compound of formula 1 a including N-end Rule pathway inhibitors disclosure the composition. According to type 1 and type 2 herein each compounds recognizing substrate UBR box and a ClpS box a mammal having two tolerance N-e
Building Units for N-Backbone Cyclic Peptides. 3. Synthesis of Protected Nα-(ω-Aminoalkyl)amino Acids and Nα-(ω-Carboxyalkyl)amino Acids
Muller, Dan,Zeltser, Irena,Bitan, Gal,Gilon, Chaim
, p. 411 - 416 (2007/10/03)
An improved synthesis of a family of amino acids that contain ω-aminoalkyl groups and of a new family containing ω-carboxyalkyl groups linked to the α-amine is described. The synthesis was performed by alkylation of suitably monoprotected alkylenediamines and protected ω-amino acids with triflates of α-hydroxy acid esters. The reaction proceeded with inversion of configuration yielding optically pure products. The Nα-(ω-aminoalkyl)amino acids and Nα-(ω-carboxyalkyl)amino acids were orthogonally protected to allow their incorporation into peptides by solid-phase peptide synthesis (SPPS) methodology.
